Hemostasis Products Market Size, Share, Value and Forecast 2032

Hemostasis Products Market Insights

According to a report from Zion Market Research, the global Hemostasis Products Market was valued at USD 1603.99 Million in 2023 and is projected to hit USD 2553.04 Million by 2032, with a compound annual growth rate (CAGR) of 5.3% during the forecast period 2024-2032. This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Hemostasis Products Market industry over the next decade.

Request Free Sample

Hemostasis Products Market: Overview

Hemostat products are medical devices used to cease bleeding and hemorrhage caused by injuries and surgical procedures. Hemostatic comprises thrombin and collagen and they are superior to surgical hemostasis alone in controlling microvascular bleeding during cardiac surgery.  It is also reasonable to use fibrin sealants as an adjunct to surgical hemostasis to limit bleeding in cardiac and aortic surgery. The devices are used to prevent blood loss in various conditions, especially in endoscopic procedures.

The players in the market are focusing on product launches, and mergers & acquisitions in order to increase the customer base across the globe. For instance, in 2020, Ethicon, part of Johnson & Johnson launched Surgical Powder Absorbable hemostat in Australia, New Zealand, and Thailand.

Global Hemostasis Products industry has seen a slight decline in revenues in the short term. Because of the pandemic, the production and supply chain stopped operating around the world, potentially reducing the use of the products. However, in the midst of the pandemic, there has been a surge in product demand for applications such as Surgery, Hemophilia, Myocardial Infarction, Stroke, and others. Also, a pharmaceutical industry that is coming under the essential services is likely to boost the use of Hemostasis Products contributing to the growth of the market.  

The global markets are slowly opening to their full potential and theirs a surge in demand for Hemostasis Products. The market would remain bullish in the upcoming year. The significant decrease in the global Hemostasis Products market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.

Hemostasis Products Market: Growth Factors

The hemostasis products market is likely to see noticeable development in the years to come on the back of increasing demand supported by growing surgery volumes. In addition to this, emerging market in developing nations is likely to unlock new growth opportunities for the hemostasis products market in the years to come.

Furthermore, the rising prevalence of chronic conditions and rapid increment in the aged population base are other factors driving the global hemostasis products market. As per the CDC statistics, over 45% of the population in the U.S suffers from a minimum of one chronic disease that needs important care, boosting the hemostasis products market. On the other hand, the slow acceptance of enhanced hemostasis instruments in up-and-coming economies and the high price of machines might hinder the growth of the hemostasis products market in the near future.

Hemostasis Products Market: Segment Analysis

On the basis of Products, the Hemostasis Products market has been divided into Topical Hemostasis, Infusible Hemostasis, and Advanced Hemostasis. The topical Hemostasis segment is further bifurcated into Collagen, Oxidized Regenerated Cellulose, Gelatin, and polysaccharides. The infusible Hemostasis segment is further bifurcated into Platelet Concentrates from Donor Blood, FVIII Derived from Blood Plasma, and Prothrombin Complex. Advanced Hemostasis is further sub-segmented into Flowable, Thrombin, Fibrin, and Synthetic Sealants. The topical hemostats segment held the major share in the market. They are used with conventional treatment to provide cost-efficiency, quick and easy absorbability of the hemostatic agent, minimal tissue reactivity, and non-antigenicity. 

On the basis of Application, the market is segmented into Trauma, Surgery, Hemophilia, Myocardial Infarction, Stroke, and Thrombosis Applications. Surgery dominated the Hemostasis Products industry in 2020, accounting for almost 35.5% of total Hemostasis Products sales. In the near future, the global Hemostasis Products industry is expected to be dominated by the Surgery application division

Hemostasis Products Market: Report Scope

Hemostasis Products Market: Regional Analysis

North America ruled the hemostasis products market and added up to more than a 33% share of the revenues of the global hemostasis products market. The area is likely to see development in the hemostasis products market at a considerable speed in the near future. The increasing numbers of complex surgeries and trauma cases, high investment is R&D, and the growth of the geriatric population are also boosting the hemostasis products market in North America.

Request Free Sample

Key Market Players & Competitive Landscape

The major players operating Hemostasis Products market are

• Pfizer, Inc.
• Medtronic plc
• Abbott Laboratories
• Johnson & Johnson
• Integra LifeSciences Corporation
• HemCon Medical Technologies, Inc.
• Grifols, S.A.
• CSL Behring LLC
• C. R. Bard, Inc
• Baxter International, Inc

The global Hemostasis Products Market is segmented as follows:

By Products

• Topical Hemostasis
  • Collagen
  • Oxidized Regenerated Cellulose
  • Gelatin
  • Polysaccharide
• Infusible Hemostasis
  • Platelet Concentrates from Donor Blood
  • FVIII Derived from Blood
  • Fresh Frozen Plasma
  • Prothrombin Complex
• Advanced Hemostasis
  • Flowable
  • Thrombin
  • Fibrin
  • Synthetic Sealants

By Application  

• Trauma
• Surgery
• Hemophilia
• Myocardial Infarction
• Stroke
• Thrombosis

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa